Correlation Between Revelation Biosciences and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and DiaMedica Therapeutics, you can compare the effects of market volatilities on Revelation Biosciences and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and DiaMedica Therapeutics.
Diversification Opportunities for Revelation Biosciences and DiaMedica Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Revelation and DiaMedica is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Revelation Biosciences and DiaMedica Therapeutics
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the DiaMedica Therapeutics. In addition to that, Revelation Biosciences is 2.44 times more volatile than DiaMedica Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest 429.00 in DiaMedica Therapeutics on September 12, 2024 and sell it today you would earn a total of 87.00 from holding DiaMedica Therapeutics or generate 20.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revelation Biosciences vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Revelation Biosciences |
| DiaMedica Therapeutics |
Revelation Biosciences and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and DiaMedica Therapeutics
The main advantage of trading using opposite Revelation Biosciences and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |